We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
501
CALL
AstraZeneca
AZN
$250B
-7,500
Closed -$10.3K
BAX icon
502
CALL
Baxter International
BAX
$14.1B
-90,000
Closed -$18K
BBIO icon
503
CALL
BridgeBio Pharma
BBIO
$16.3B
-35,000
Closed -$4.38K
BEAM icon
504
CALL
Beam Therapeutics
BEAM
$2.86B
-30,000
Closed -$12K
BOX icon
505
Box
BOX
$4.56B
-150,000
Closed -$3.97M
BPMC
506
PUT
DELISTED
Blueprint Medicines
BPMC
-20,000
Closed -$51K
BTG icon
507
B2Gold
BTG
$6.22B
-334,874
Closed -$904K
CARG icon
508
CarGurus
CARG
$3.61B
-65,000
Closed -$1.7M
CARR icon
509
Carrier Global
CARR
$52.7B
-61,600
Closed -$3.89M
CDNS icon
510
Cadence Design Systems
CDNS
$95.1B
-38,000
Closed -$11.7M
COHR icon
511
Coherent
COHR
$73.5B
-20,000
Closed -$1.45M
COP icon
512
ConocoPhillips
COP
$141B
-42,316
Closed -$4.84M
CP icon
513
Canadian Pacific Kansas City
CP
$80B
-83,000
Closed -$6.53M
CRC icon
514
California Resources
CRC
$4.63B
-14,046
Closed -$748K
CRDF icon
515
Cardiff Oncology
CRDF
$76.6M
-150,000
Closed -$333K
CRH icon
516
CRH
CRH
$66.2B
-177,000
Closed -$13.3M
CRSP icon
517
PUT
CRISPR Therapeutics
CRSP
$5.17B
-15,000
Closed -$25.5K
CYH icon
518
CALL
Community Health Systems
CYH
$420M
-525,000
Closed -$88.1K
CYTK icon
519
CALL
Cytokinetics
CYTK
$10.4B
-23,000
Closed -$17.8K
DASH icon
520
DoorDash
DASH
$96B
-52,500
Closed -$5.71M
DELL icon
521
Dell
DELL
$276B
-29,576
Closed -$4.08M
DHR icon
522
PUT
Danaher
DHR
$142B
-10,000
Closed -$54.5K
DOCU
523
DocuSign
DOCU
$11.4B
-35,000
Closed -$1.87M
DOV icon
524
Dover
DOV
$28.7B
-97,700
Closed -$17.6M
DXCM icon
525
PUT
DexCom
DXCM
$31.6B
-15,000
Closed -$25.9K

Similar funds

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.